Rinri Therapeutics

Rinri Therapeutics

Founded in 2018, Rinri Therapeutics Ltd. is a therapeutic discovery and development company working in the field of hearing loss supported by Boehringer Ingelheim and UCB Venture Funds, BioCity and The University of Sheffield.

Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.

The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.

What is the origin of the name?
‘Rinri’ means ear in Quechua, a language spoken by some of the original people of South America.